BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 11733927)

  • 1. The use of dipyridamole to wean from inhaled nitric oxide in congenital diaphragmatic hernia.
    Buysse C; Fonteyne C; Dessy H; De Laet MH; Biarent D
    J Pediatr Surg; 2001 Dec; 36(12):1864-5. PubMed ID: 11733927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dypiridamole, a cGMP phosphodiesterase inhibitor, transiently improves the response to inhaled nitric oxide in two newborns with congenital diaphragmatic hernia.
    Thébaud B; Saizou C; Farnoux C; Hartman JF; Mercier JC
    Intensive Care Med; 1999 Mar; 25(3):300-3. PubMed ID: 10229165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of need for extracorporeal membrane oxygenation support in neonates with congenital diaphragmatic hernia treated with inhaled nitric oxide.
    Sebald M; Friedlich P; Burns C; Stein J; Noori S; Ramanathan R; Seri I
    J Perinatol; 2004 Mar; 24(3):143-6. PubMed ID: 14961042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term inhaled nitric oxide plus dipyridamole for pulmonary arterial hypertension.
    Pérez-Peñate G; Cabrera Navarro P; Ponce González M; Górriz Gómez E; Pulido Duque J; García Quintana A; Juliá Serdá G
    Respiration; 2005; 72(4):419-22. PubMed ID: 16088287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemodynamic effects of inhaled nitric oxide and phosphodiesterase inhibitor (dipyridamole) on secondary pulmonary hypertension following heart valve surgery in adults.
    Santini F; Casali G; Franchi G; Auriemma S; Lusini M; Barozzi L; Favaro A; Messina A; Mazzucco A
    Int J Cardiol; 2005 Aug; 103(2):156-63. PubMed ID: 16080974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of dipyridamole and inhaled nitric oxide in pediatric patients with pulmonary hypertension.
    Ziegler JW; Ivy DD; Wiggins JW; Kinsella JP; Clarke WR; Abman SH
    Am J Respir Crit Care Med; 1998 Nov; 158(5 Pt 1):1388-95. PubMed ID: 9817684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of L-arginine [correction of F-arginine] and phosphodiesterase inhibitor (dipyridamole) to wean from inhaled nitric oxide.
    Saidy K; al-Alaiyan S
    Indian J Pediatr; 2001 Feb; 68(2):175-7. PubMed ID: 11284188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Persistent pulmonary hypertension in premature and newborn infants: selective pulmonary vasodilation with inhaled nitric oxide (iNO)].
    Herkenhoff M; Schaible T; Reiss I; Kandzora J; Möller J; Gortner L
    Z Geburtshilfe Neonatol; 1998; 202(1):25-9. PubMed ID: 9577919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dipyridamole attenuates rebound pulmonary hypertension after inhaled nitric oxide withdrawal in postoperative congenital heart disease.
    Ivy DD; Kinsella JP; Ziegler JW; Abman SH
    J Thorac Cardiovasc Surg; 1998 Apr; 115(4):875-82. PubMed ID: 9576224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early outcome of congenital diaphragmatic hernia in a Malaysian tertiary centre.
    Rohana J; Boo NY; Thambidorai CR
    Singapore Med J; 2008 Feb; 49(2):142-4. PubMed ID: 18301842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhaled nitric oxide and hypoxic respiratory failure in infants with congenital diaphragmatic hernia. The Neonatal Inhaled Nitric Oxide Study Group (NINOS).
    Pediatrics; 1997 Jun; 99(6):838-45. PubMed ID: 9190553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhaled nitric oxide use in neonates with congenital diaphragmatic hernia.
    Campbell BT; Herbst KW; Briden KE; Neff S; Ruscher KA; Hagadorn JI
    Pediatrics; 2014 Aug; 134(2):e420-6. PubMed ID: 25022736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhaled nitric oxide in the neonate.
    Soll RF
    J Perinatol; 2009 May; 29 Suppl 2():S63-7. PubMed ID: 19399012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retrospective study of 111 cases of congenital diaphragmatic hernia treated with early high-frequency oscillatory ventilation and presurgical stabilization.
    Migliazza L; Bellan C; Alberti D; Auriemma A; Burgio G; Locatelli G; Colombo A
    J Pediatr Surg; 2007 Sep; 42(9):1526-32. PubMed ID: 17848243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of inhaled nitric oxide in newborn medicine.
    Golombek SG
    Heart Dis; 2000; 2(5):342-7. PubMed ID: 11728280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhaled nitric oxide decreases pulmonary soluble guanylate cyclase protein levels in 1-month-old lambs.
    Thelitz S; Bekker JM; Ovadia B; Stuart RB; Johengen MJ; Black SM; Fineman JR
    J Thorac Cardiovasc Surg; 2004 May; 127(5):1285-92. PubMed ID: 15115984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurally adjusted ventilatory assist mode used in congenital diaphragmatic hernia.
    Durrani NU; Chedid F; Rahmani A
    J Coll Physicians Surg Pak; 2011 Oct; 21(10):637-9. PubMed ID: 22015130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Congenital diaphragmatic hernia: intensive care unit or operating room?
    Lago P; Meneghini L; Chiandetti L; Tormena F; Metrangolo S; Gamba P
    Am J Perinatol; 2005 May; 22(4):189-97. PubMed ID: 15906212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The outcome in newborns with congenital diaphragmatic hernia in a Norwegian region.
    Fredly S; Aksnes G; Viddal KO; Lindemann R; Fugelseth D
    Acta Paediatr; 2009 Jan; 98(1):107-11. PubMed ID: 18795908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of phosphodiesterase inhibitor (dipyridamole) to wean from inhaled nitric oxide.
    al-Alaiyan S; al-Omran A; Dyer D
    Intensive Care Med; 1996 Oct; 22(10):1093-5. PubMed ID: 8923076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.